At the time of writing, Trxade Health Inc [MEDS] stock is trading at $17.26, up 107.21%. An important factor to consider is whether the stock is rising or falling in short-term value. The MEDS shares have gain 103.06% over the last week, with a monthly amount glided 314.90%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 6, March 2024, TRxADE Health, Inc. Announces Special Cash Dividend. In a post published today on Yahoo Finance, TRxADE HEALTH Inc. (Nasdaq: MEDS), announced that the Company’s board of directors has declared a special cash dividend of $8.00 per share of common stock. The special dividend is being paid using a portion of the proceeds from the closing of the recently announced sale of the Company’s web-based market platform assets. The special cash dividend is payable to stockholders of record as of March 18, 2024, with the dividend being paid on or about March 22, 2024.
From an analyst’s perspective:
For the past year, the stock price of Trxade Health Inc fluctuated between $3.69 and $19.70. Trxade Health Inc [NASDAQ: MEDS] shares were valued at $17.26 at the most recent close of the market.
Analyzing the MEDS fundamentals
According to Trxade Health Inc [NASDAQ:MEDS], the company’s sales were 9.09M for trailing twelve months, which represents an -14.26% plunge. Gross Profit Margin for this corporation currently stands at 0.71% with Operating Profit Margin at -0.2%, Pretax Profit Margin comes in at -0.42%, and Net Profit Margin reading is -0.81%. To continue investigating profitability, this company’s Return on Assets is posted at -0.34, Equity is -2.51 and Total Capital is -0.14. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.56.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 11.60 points at the first support level, and at 5.94 for the second support level. However, for the 1st resistance point, the stock is sitting at 22.07, and for the 2nd resistance point, it is at 26.88.
Trxade Health Inc [MEDS] reported earnings per share of -$2.9 for its fiscal quarter that ended on 6/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.75/share, meaning a difference of -$2.15 and a surprise factor of -286.70%. By comparison, the stated earnings for the previous quarter ended on 3/30/2023 were -$0.45 per share as compared to estimates of -$0.45 per share, a difference of $0 representing a surprise of 0.00%.
Ratios To Look Out For
It is important to note that Trxade Health Inc [NASDAQ:MEDS] has a current ratio of 0.61. On the other hand, the Quick Ratio is 0.28, and the Cash Ratio is 0.0. Considering the valuation of this stock, the price to sales ratio is 2.30, the price to book ratio is 1.22.
